Submitted:
02 September 2024
Posted:
03 September 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design Cohort
2.2. Algorithm Defining DS
- Having birth certificate indication for “karyotype confirmed” DS
- Having birth certificate indication for “karyotype pending” DS or just DS if test type was not specified (i.e., prior to 2004) and having at least two healthcare encounters for DS during the first six years of life
- Having at least three healthcare encounters for DS during the first six years of life, with the first and last encounter separated by at least 30 days
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Stallings, E.B.; Isenburg, J.L.; Rutkowski, R.E.; Kirby, R.S.; Nembhard, W.N.; Sandidge, T.; Villavicencio, S.; Nguyen, H.H.; McMahon, D.M.; Nestoridi, E.; Pabst, L.J.; National Birth Defects Prevention, N. National population-based estimates for major birth defects, 2016-2020. Birth Defects Res 2024, 116, e2301. [Google Scholar] [CrossRef] [PubMed]
- Antonarakis, S.E.; Skotko, B.G.; Rafii, M.S.; Strydom, A.; Pape, S.E.; Bianchi, D.W.; Sherman, S.L.; Reeves, R.H. Down syndrome. Nat Rev Dis Primers 2020, 6, 9. [Google Scholar] [CrossRef] [PubMed]
- Bull, M.J.; Trotter, T.; Santoro, S.L.; Christensen, C.; Grout, R.W.; Council On, G.; Burke, L.W.; Berry, S.A.; Geleske, T.A.; Holm, I.; Hopkin, R.J.; Introne, W.J.; Lyons, M.J.; Monteil, D.C.; Scheuerle, A.; Stoler, J.M.; Vergano, S.A.; Chen, E.; Hamid, R.; Downs, S.M.; Grout, R.W.; Cunniff, C.; Parisi, M.A.; Ralston, S.J.; Scott, J.A.; Shapira, S.K.; Spire, P. Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics 2022, 149. [Google Scholar] [CrossRef] [PubMed]
- National Institute of Health. https://www.nih.gov/include-project (April 3).
- Quan, H.; Parsons, G.A.; Ghali, W.A. Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care 2004, 42, 801–809. [Google Scholar] [CrossRef] [PubMed]
- van Walraven, C.; Austin, P. Administrative database research has unique characteristics that can risk biased results. J Clin Epidemiol 2012, 65, 126–131. [Google Scholar] [CrossRef] [PubMed]
- Lash, T.L.; Mor, V.; Wieland, D.; Ferrucci, L.; Satariano, W.; Silliman, R.A. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci 2007, 62, 281–285. [Google Scholar] [CrossRef] [PubMed]
- Romano, P.S.; Chan, B.K.; Schembri, M.E.; Rainwater, J.A. Can administrative data be used to compare postoperative complication rates across hospitals? Med Care 2002, 40, 856–867. [Google Scholar] [CrossRef] [PubMed]
- Romano, P.S.; Schembri, M.E.; Rainwater, J.A. Can administrative data be used to ascertain clinically significant postoperative complications? Am J Med Qual 2002, 17, 145–154. [Google Scholar] [CrossRef] [PubMed]
- Jensen, K.M.; Cooke, C.R.; Davis, M.M. Fidelity of administrative data when researching Down syndrome. Med Care 2014, 52, e52–e57. [Google Scholar] [CrossRef] [PubMed]
- Brown, L.D.; Cai, T.T.; DasGupta, A.; Agresti, A.; Coull, B.A.; Casella, G.; Corcoran, C.; Mehta, C.; Ghosh, M.; Santner, T.J.; Brown, L.D.; Cai, T.T.; DasGupta, A. Interval estimation for a binomial proportion - Comment - Rejoinder. Stat Sci 2001, 16, 101–133. [Google Scholar] [CrossRef]
- Northam, S.; Polancich, S.; Restrepo, E. Birth certificate methods in five hospitals. Public Health Nurs 2003, 20, 318–327. [Google Scholar] [CrossRef] [PubMed]
- Natoli, J.L.; Ackerman, D.L.; McDermott, S.; Edwards, J.G. Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011). Prenat Diagn 2012, 32, 142–153. [Google Scholar] [CrossRef] [PubMed]
- Shin, M.; Kucik, J.E.; Correa, A. Causes of death and case fatality rates among infants with down syndrome in metropolitan Atlanta. Birth Defects Res A Clin Mol Teratol 2007, 79, 775–780. [Google Scholar] [CrossRef] [PubMed]

| Qualified for suspected DS | Confirmed DS | Total (n=411) | |
|---|---|---|---|
| Yes (n=354) | No (n=57) | ||
| Having at least one ICD code specific for DS | 354 (100%) | 57 (100%) | 411 (100%) |
| DS coded on birth certificate | 101 (28.5%) | 1 (<1%) | 102 (24.8%) |
| Children with suspected DS (n=411) | ||
|---|---|---|
| Maternal characteristics | ||
| Age at delivery | 31 (23, 38) | |
| Education (n=410) | ||
| Some high school or less | 108 (26.3%) | |
| High school graduate | 133 (32.4%) | |
| At least some college education | 169 (41.2%) | |
| Residence | ||
| Urban | 134 (32.6%) | |
| Suburban | 136 (33.1%) | |
| Rural | 141 (34.3%) | |
| Married | 241 (58.6%) | |
| Smoking during pregnancy (n=409) | 72 (17.6%) | |
| Prenatal care started at first trimester (n=381) | 264 (69.3%) | |
| Parity (n=405) | ||
| Primiparous | 123 (30.4%) | |
| 2 | 116 (28.6%) | |
| 3+ | 166 (40.9%) | |
| Delivery method | ||
| Vaginal/assisted | 217 (52.8%) | |
| Cesarean section | 194 (47.2%) | |
| Infant characteristics | ||
| Male sex | 224 (54.5%) | |
| Race and Ethnicity | ||
| Non-Hispanic White | 209 (50.9%) | |
| Non-Hispanic Black | --1 | |
| Hispanic | --1 | |
| Other | --1 | |
| Gestational age in weeks | 38 (36, 39) | |
| Birth weight in grams | 2920 (2495, 3280) | |
| Small-for-gestational-age at 10th percentile (n=410) | 59 (14.4%) | |
| Singleton birth | 404 (98.3%) | |
| One or more older siblings (n=406) | 283 (69.7%) | |
| Congenital heart disease | 343 (83.5%) | |
| Birth year | ||
| 2000-2004 | 74 (18.0%) | |
| 2005-2009 | 118 (28.7%) | |
| 2010-2017 | 219 (53.3%) |
| Criterion 1 (karyotype confirmed DS) |
Criterion 2 (karyotype pending DS or just DS and ≥2 ICD diagnosis for DS) |
Criterion 3 (≥3 ICD diagnosis for DS) |
Study population - children with suspected DS (N=411) |
Children with chart review confirmed DS (N=354) | Children with chart review confirmed no DS (N=57) | PPV |
|---|---|---|---|---|---|---|
| X | 1 | 1 | 0 | 100.0% | ||
| X | X | 34 | 34 | 0 | 100.0% | |
| X | 3 | 3 | 0 | 100.0% | ||
| X | X | 63 | 63 | 0 | 100.0% | |
| X | 253 | 246 | 71 | 97.2% | ||
| 57 | 72 | 50 | NA |
| N (%) | ||
|---|---|---|
| Type (N=2831) | ||
| Trisomy 21 nondisjunction (de novo mutation) | 266 (94.0%) | |
| Translocation/Mosaic | 17 (6.0%) | |
| Diagnosis method2 (N=2931) | ||
| Amniocentesis/Chorionic villus sampling | 47 (16.0%) | |
| Karyotype | 227 (77.5%) | |
| Fluorescence in situ hybridization | 20 (6.8%) | |
| Timing of first diagnosis (N=2931) | ||
| Prenatal | 83 (28.3%) | |
| Postnatal | 210 (71.7%) | |
| Infant age in days when first DS specific ICD diagnosis appeared in claims data | 0 (0, 40)3 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).